GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE Uses, Dosage, Side Effects, Food Interaction and all others data.

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).

Trade Name GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
Generic Gastric inhibitory polypeptide
Gastric inhibitory polypeptide Other Names GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE

Innovators Monograph

You find simplified version here GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE

*** Taking medicines without doctor's advice can cause long-term problems.
Share